Lactobacillus Acidophilus/Streptococcus Thermophilus/Bifidobacterium Lactis/L. Rhamnosus/B. Longum/B. Bifidum-Based Probiotic Supplement.

Bifidobacterium longum and B. lactis carry the transport and cleavage machinery for fructans, so inulin feeds precisely the organisms in this blend. Fermentation yields acetate and lactate, which cross-feeding species convert onward. Pairing a fructan with a bifidobacteria-containing blend is the textbook synbiotic construction.

Galactooligosaccharides resist human digestive enzymes and reach the colon intact, where bifidobacteria import them whole and cleave them internally. That internal cleavage is why GOS favour these genera over faster surface-degrading competitors. The pairing supplies both the organism and its preferred carbohydrate.

FOS are the shorter chain-length end of the fructan family and ferment faster and more proximally than long chain inulin. Faster fermentation means more gas produced over a shorter stretch of colon, which is why tolerance differs between the two at the same gram dose. Both feed the bifidobacteria in the blend.

Resistant starch is degraded mainly by primary starch degraders, whose lactate and acetate output is then used by butyrate producers. Lactobacilli and bifidobacteria in this blend contribute lactate to that same pool. The relationship is cross-feeding within a community rather than one organism eating one fibre.

Bifidobacteria and lactobacilli produce acetate and lactate, not butyrate. Butyrate-producing species such as those in the Faecalibacterium and Anaerostipes groups take up that lactate and acetate and convert them onward. Supplying butyrate directly and supplying its upstream producers arrive at the same molecule by different routes.

S. thermophilus delivers bacterial beta-galactosidase into the small intestine, where it hydrolyses lactose alongside any supplemental lactase taken. Both act on the same disaccharide bond. The bacterial route depends on the organisms surviving gastric transit, while a purified enzyme does not.

Being a yeast, S. boulardii does not share bacterial transport systems or bacterial antibiotic susceptibility, so it occupies a different niche from the six bacterial strains here. The two are commonly formulated in sequence rather than in one capsule because their storage requirements differ. The pairing broadens the organisms delivered rather than reinforcing one.

Partially hydrolysed guar gum ferments more slowly and more distally than fructans, which changes the gas profile at the same fibre intake. It supports the same saccharolytic community the blend contributes to. Where fructan tolerance is the limiting factor, this is the substrate usually substituted.

Beta-glucan raises luminal viscosity in the small intestine and is fermented in the colon to short chain fatty acids. That slows transit slightly, which extends the contact time for delivered organisms. It is a broader substrate than a fructan and is not bifidogenic in the same targeted way.

Pectin degradation requires a set of esterases and lyases that only some colonic genera carry, so its output reaches the blend's strains as cross-fed sugars and acids rather than direct substrate. It also gels in the stomach, which can slow gastric emptying. Read the pairing as community-level rather than strain-specific.

Psyllium is only partly fermented, so it acts mainly on stool consistency and transit rather than as a bacterial food. Changing transit changes how long delivered organisms sit in each colonic segment. It is a bulking partner rather than a prebiotic one, and mixing the two categories is a common labelling error.

Lactoferrin binds ferric iron tightly and withholds it from bacteria that need it to grow. Lactobacilli are unusual in managing with very little iron, so iron withholding shifts the competitive balance in their favour. This is a selective pressure argument, not a measured clinical outcome of the pairing.

Glutamine feeds the host epithelium directly while colonic fermentation from these strains feeds the colonocyte through short chain fatty acids. The two supply different segments of the same tissue. They are complements in a gut formulation rather than acting on each other.

Zinc carnosine dissociates slowly at the mucosal surface and delivers zinc, a cofactor for the enzymes involved in epithelial turnover. It does not feed or inhibit the delivered organisms. The pairing is a formulation convention aimed at two different layers of the same tissue.

Colostrum contains sialylated oligosaccharides structurally related to the human milk oligosaccharides that bifidobacteria are adapted to consume. It also carries IgG that binds bacterial surface antigens indiscriminately. The net effect on a delivered strain blend is not something a single mechanism settles.

Charcoal's surface adsorbs bacterial metabolites and can bind the organisms and their substrates within the same lumen. Taking it with a probiotic works against what the probiotic is there to do. Separating the two by several hours is the standard formulation answer.

Bentonite binds cations and organic material along the gut lumen without discriminating between what is wanted and what is not. Bacterial cells and their exchanged metabolites are within its adsorption range. Co-dosing with live organisms is not a productive pairing.

Oregano oil phenols permeabilise bacterial membranes without sparing lactobacilli and bifidobacteria. Taken in the same window as a live culture, they reduce the number of organisms that arrive intact. Sequencing the two rather than co-dosing is the usual approach.

Berberine is poorly absorbed, so most of an oral dose stays in the lumen where delivered organisms sit. Its antibacterial activity is not selective for unwanted species. The direction of the net effect on a specific strain blend is not established, which is why this is flagged rather than recommended.

Allicin reacts with bacterial thiol groups and does not spare lactic acid bacteria. Fresh garlic preparations carry more of the reactive thiosulfinates than aged extracts. Timing separation matters more than dose here.

Protease-containing enzyme blends act on any protein in the lumen, including the surface layer proteins lactobacilli use to attach to mucus. Delivered cells sit in the same compartment as the enzyme dose. The practical significance depends on the enzyme activity level and is not well quantified.

Certain lactic acid bacteria carry an intact riboflavin biosynthesis operon and release the vitamin into the lumen. Whether that reaches the host depends on colonic riboflavin transport, which is present but limited. Read this as a microbial capability, not a substitute for dietary intake.

Menaquinone is part of the bacterial electron transport chain, and colonic species produce a range of chain lengths. Absorption of bacterially made menaquinone from the colon is limited compared with dietary intake. This is a shared biochemistry note rather than a dosing strategy.